DE3873688D1 - Stabilisierte pergolidzubereitungen. - Google Patents

Stabilisierte pergolidzubereitungen.

Info

Publication number
DE3873688D1
DE3873688D1 DE8888309848T DE3873688T DE3873688D1 DE 3873688 D1 DE3873688 D1 DE 3873688D1 DE 8888309848 T DE8888309848 T DE 8888309848T DE 3873688 T DE3873688 T DE 3873688T DE 3873688 D1 DE3873688 D1 DE 3873688D1
Authority
DE
Germany
Prior art keywords
stabilized
pergolide
preparations
polyvinylpyrrolidone
decomposition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888309848T
Other languages
English (en)
Other versions
DE3873688T2 (de
Inventor
James William Conine
Julian Larry Stowers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE3873688D1 publication Critical patent/DE3873688D1/de
Application granted granted Critical
Publication of DE3873688T2 publication Critical patent/DE3873688T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE8888309848T 1987-10-26 1988-10-20 Stabilisierte pergolidzubereitungen. Expired - Lifetime DE3873688T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/112,360 US4797405A (en) 1987-10-26 1987-10-26 Stabilized pergolide compositions

Publications (2)

Publication Number Publication Date
DE3873688D1 true DE3873688D1 (de) 1992-09-17
DE3873688T2 DE3873688T2 (de) 1993-03-11

Family

ID=22343489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888309848T Expired - Lifetime DE3873688T2 (de) 1987-10-26 1988-10-20 Stabilisierte pergolidzubereitungen.

Country Status (17)

Country Link
US (1) US4797405A (de)
EP (1) EP0314387B1 (de)
JP (1) JP2747303B2 (de)
KR (1) KR960013284B1 (de)
AT (1) ATE79258T1 (de)
AU (1) AU611494B2 (de)
CA (1) CA1318253C (de)
DE (1) DE3873688T2 (de)
DK (1) DK174831B1 (de)
ES (1) ES2042760T3 (de)
GR (1) GR3005784T3 (de)
HU (1) HU200691B (de)
IE (1) IE61960B1 (de)
IL (1) IL88087A (de)
NZ (1) NZ226650A (de)
PH (1) PH25575A (de)
ZA (1) ZA887805B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
EP1245232B1 (de) * 1999-11-11 2006-01-25 Kyorin Pharmaceutical Co., Ltd. Orale feste zusammensetzung
AU2001286418A1 (en) * 2000-08-08 2002-02-18 Teva Pharmaceutical Industries Ltd. Stable pergolide mesylate and process for making same
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2003080030A1 (en) * 2002-03-26 2003-10-02 Bernard Charles Sherman Stable tablets comprising pergolide mesylate
KR101302118B1 (ko) * 2011-04-22 2013-08-30 한림대학교 산학협력단 단백질 수송 도메인과 치료용 단백질이 공유결합한 융합 단백질에 퍼골라이드를 가하여 융합 단백질의 생체 세포 또는 조직 내 도입을 증가시키는 방법
US20190374534A1 (en) * 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US4473565A (en) * 1976-05-13 1984-09-25 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS5399316A (en) * 1977-02-04 1978-08-30 Sanpo Seiyaku Kk Stbilyzing method of leserpine preparation
AT362051B (de) * 1977-04-05 1981-04-27 Sandoz Ag Verfahren zur herstellung von injektions- praeparaten
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4329366A (en) * 1979-11-08 1982-05-11 Johnson & Johnson Products, Inc. Topical acylaminophenols
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
JPS58105913A (ja) * 1981-12-18 1983-06-24 Nippon Chemiphar Co Ltd ニフエジピン軟カプセル剤
JPS58206533A (ja) * 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
JPS6176416A (ja) * 1984-09-20 1986-04-18 Fujimoto Seiyaku Kk 活性型ビタミンｄ↓３誘導体のカプセル剤用組成物
JPS6270317A (ja) * 1985-09-24 1987-03-31 Sawai Seiyaku Kk 活性型ビタミンｄ↓３類含有製剤
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten

Also Published As

Publication number Publication date
AU611494B2 (en) 1991-06-13
NZ226650A (en) 1990-08-28
CA1318253C (en) 1993-05-25
ZA887805B (en) 1990-06-27
KR890006238A (ko) 1989-06-12
PH25575A (en) 1991-08-08
HUT48462A (en) 1989-06-28
KR960013284B1 (ko) 1996-10-02
ATE79258T1 (de) 1992-08-15
HU200691B (en) 1990-08-28
IE883199L (en) 1989-04-26
DK583188D0 (da) 1988-10-20
EP0314387B1 (de) 1992-08-12
IL88087A0 (en) 1989-06-30
ES2042760T3 (es) 1993-12-16
JPH01146821A (ja) 1989-06-08
GR3005784T3 (de) 1993-06-07
DK583188A (da) 1989-04-27
JP2747303B2 (ja) 1998-05-06
IE61960B1 (en) 1994-11-30
DK174831B1 (da) 2003-12-08
IL88087A (en) 1992-09-06
AU2408088A (en) 1989-04-27
DE3873688T2 (de) 1993-03-11
US4797405A (en) 1989-01-10
EP0314387A1 (de) 1989-05-03

Similar Documents

Publication Publication Date Title
ATE79258T1 (de) Stabilisierte pergolidzubereitungen.
AR246959A1 (es) Derivados de n-fenilpirazol y composiciones plaguicidas que los contienen, excluyendo su aplicacion en seres humanos y animales superiores, y procedimiento para preparar dichos derivados.
ES2104605T3 (es) Composiciones estables de acido ascorbico.
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
FI934274A0 (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
DK25587A (da) Toer, stabiliseret, partikelformig, fritstroemmende tocopherolsammensaetning
NZ218028A (en) Benzimidazole derivatives and pharmaceutical compositions
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
SE8404065D0 (sv) Novel biologically active compounds
DK4481A (da) Hydroxyalkylstivelse som laegemiddelbaerer
ATE59294T1 (de) Stabilisierte arzneimittel.
NZ248794A (en) 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments
DE69007164D1 (de) Antirhinovirale (Thio)morpholinyl- und Piperazinyl-Alkylphenolether.
ES2043959T3 (es) Preparado farmaceutico estabilizado, que contiene n-acetilcisteina.
NO911119D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk jodpreparat
ATE6587T1 (de) Antimikrobielles praeparat.
DE3573707D1 (de) Anticoccidial compostions
ATE18761T1 (de) Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen.
ATE123497T1 (de) Substituierte pyridin-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FI894068A (fi) Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae

Legal Events

Date Code Title Description
8364 No opposition during term of opposition